Used in the treatment of type 1 diabetes by targeting and modulating T cells to delay disease progression. It binds to the CD3 complex on T cells, reducing the autoimmune attack on insulin-producing beta cells in the pancreas. Employed in clinical settings to preserve beta cell function in newly diagnosed patients, especially in pediatric and adolescent populations. Also utilized as a reference standard in immunoassay development and therapeutic antibody research.